Inhibrx Biosciences, Inc. Revenue 2023–2025
Inhibrx Biosciences, Inc. annual/quarterly revenue history and growth rate from 2023 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Inhibrx Biosciences, Inc. revenue for the quarter ending September 30, 2025 was 0.
- Inhibrx Biosciences, Inc. revenue for the twelve months ending September 30, 2025 was 1.3 M, a 422.09% increase year-over-year.
- Inhibrx Biosciences, Inc. annual revenue for 2025 was 1.3 M, a 550.00% increase from 2024.
- Inhibrx Biosciences, Inc. annual revenue for 2024 was 200000, a 88.89% decrease from 2023.
- Inhibrx Biosciences, Inc. annual revenue for 2023 was 1.8 M.
Inhibrx Biosciences, Inc. (INBX) — Frequently Asked Questions
Inhibrx Biosciences, Inc. (INBX) is a publicly traded US company. It has a market capitalization of $1.39B. In fiscal 2025 it reported revenue of $1M and net income of -$140M. Explore INBX's stock price, financial statements, earnings history, margins and key ratios below.
What is Inhibrx Biosciences, Inc.'s market cap?
Inhibrx Biosciences, Inc. (INBX) has a market capitalization of $1.39B.
What is the INBX stock price?
INBX trades at $89.71 (+0.27% on the day).
How much revenue does Inhibrx Biosciences, Inc. make?
Inhibrx Biosciences, Inc. reported revenue of $1M in fiscal 2025.
Is INBX profitable?
In fiscal 2025, Inhibrx Biosciences, Inc. reported net income of -$140M.